Margaretha Ljungman

A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers

Rigmor Thorstensson, Birger Trollfors, Nabil Al‐Tawil et al. · PLoS ONE · 2014 · 139 citations · Full text

Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model

Elisabet Reizenstein, Hans O. Hallander, William C. Blackwelder et al. · Journal of Immunological Methods · 1995 · 96 citations

Vaccination, Medicine, Pertussis Serology +10

Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015

Alex‐Mikael Barkoff, Jussi Mertsola, Denis Piérard et al. · Eurosurveillance · 2019 · 96 citations · Full text

Seroprevalence of pertussis antitoxin (anti‐PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program

Hans O. Hallander, Mikael Andersson, Lennart Gustafsson et al. · Apmis · 2009 · 54 citations · Full text

Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study

Maja Jahnmatz, Laura Richert, Nabil Al‐Tawil et al. · The Lancet Infectious Diseases · 2020 · 53 citations · Full text

Vaccinology, Vaccine Safety, Vaccination +6